EXS 145 Guidelines for Exercise Testing & Prescription
|
|
- Scarlett Gibson
- 5 years ago
- Views:
Transcription
1 EXS 145 Guidelines for Exercise Testing & Prescription Andrew Weiler M.Ed MCCD Adjunct Faculty CGCC Employee Wellness Coordinator SRPMIC Employee Wellness Coordinator Pot & Window LLC
2 Today How to aid in development of safe exercise prescription/testing? Absolute & Relative Contraindications CAD Risk Factor Thresholds ACSM Risk Stratification Categories Exercise Testing: Risk & Supervision AHA Risk Stratification Criteria
3 Today Blood Pressure Lab 1 See one Do one Teach one
4 How to aid in development of safe exercise prescription/testing? Identify and exclude individuals with medical contraindications to exercise Identify increased risk due to: Age Symptoms Risk factors Clinically significant disease
5 How to aid in development of safe exercise prescription/testing? Why? Send for medical evaluation Possibly including exercise testing Refer to medically supervised programs Identify special needs Educate/council
6 How to aid in development of safe exercise prescription/testing? Especially screen for: Cardiovascular diseases (name a few?) Pulmonary diseases Metabolic diseases Conditions aggravated by exercise: Pregnancy Orthopedic injury Arthritis Hypertension
7 Screening Don t lose your clients (Two ways) They are inconvenienced by screening Died because you didn t screen them.
8 Professionally qualified exercise staff refers to appropriately trained individuals who possess academic training, practical & clinical knowledge, skills & abilities commensurate with the credentials defined in Appendix D.
9 The professionally guided preparticipation screening process involves: the review of more detailed health/medical history information and specific risk stratification, and detailed recommendations for physical activity/exercise, medical examination, exercise testing, and physician supervision.
10 Absolute & Relative Contraindications Table 2-2, Box 3-5 Relative: Significantly increased risk for injury with exercise Risks benefits carefully considered Absolute: Very high risk Benefit > risk is unlikely Who makes that call? Personal trainer: Don t exercise either!
11 Major Signs/Symptoms Suggestive of Cardiovascular, Pulmonary, and Metabolic Disease p26-27
12 Do you see why this is a reference tool? Major Signs/Symptoms Suggestive of Cardiovascular, Pulmonary, and Metabolic Disease p26-27
13 Known Cardiovascular, Pulmonary, and Metabolic Disease An individual has known cardiovascular, pulmonary, and/or metabolic disease if a physician has diagnosed one of the following conditions: Cardiovascular disease (CVD): cardiac, peripheral artery (PAD), or cerebrovascular disease Pulmonary disease: chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, or cystic fibrosis Metabolic disease: diabetes mellitus (type 1 or type 2), thyroid disorders, and renal or liver disease
14 CAD Risk Factor Thresholds for use With ACSM Stratification Table 2-1 Family History: MI, coronary revascularization or sudden death in: Male first-degree relative <55 y.o. Female first-degree relative <65 y.o. Cigarette smoking: Smoker in last 6 months
15 CAD Risk Factor Thresholds for use With ACSM Stratification Table 2-1 Hypertension SBP >140 mmhg DBP >90 mmhg Anti-hypertensive medication Measurements on > two separate occasions Sedentary Lifestyle >3 months F: < 3 days I: < Moderate 40-60%VO 2 R D:< 30 minutes
16 CAD Risk Factor Thresholds for use With ACSM Stratification Table 2-1 Dyslipidemia LDL >130 mg/dl Total Chol > 200 mg/dl Some say only as substitute for LDL HDL < 40 mg/dl Negative Risk Factor: HDL> 60 mg/dl Controversy: removes dyslipidemia or any RF?
17 CAD Risk Factor Thresholds for use With ACSM Stratification Table 2-1 Prediabetes (impaired fasting glucose): FPG> 100 mg/dl <126 mg/dl Confirmed on > 2 separate occasions IGT on OGTT Obesity: BMI > 30 kg/m 2 Waist girth: > 102 cm men > 88 cm women Waist/Hip > 0.95 men, > 0.86 women
18 Undisclosed or Unavailable CVD Risk Factor Information Health/fitness and exercise professionals and clinicians are encouraged to adopt a conservative approach to CVD risk factor identification for the purposes of risk stratification, especially when: risk factor information is missing, and/or the criteria for identifying the presence or absence of a specific risk factor cannot be determined or is not available.
19 Undisclosed or Unavailable CVD Risk Factor Information (cont.) If the presence or absence of a specific risk factor is not disclosed or is unavailable, the risk factor should be counted as a risk factor except for prediabetes. Missing or unknown criteria for prediabetes should be counted as a risk factor in the presence of age( 45 years), particularly for those with a body mass index 25 kg m -2 and for those who are younger, have a body mass index 25 kg m -2, and have additional risk factors for prediabetes.
20 Risk Stratification Table 2-1
21 ACSM Risk Stratification Categories Table 2-1 Low Risk Men < 45, Women <55 y.o. Asymptomatic < 1 CAD RF Moderate risk: Men > 45, Women >55 y.o. Symptomatic (not really but I say yes) > 2 CAD RF
22 ACSM Risk Stratification Categories Table 2-1 High Risk > sign/symptom table 2-3 Known cardiovascular, pulmonary, metabolic disease Look at table 2-3 again: Do you see why the GETP8 is a reference text?
23 More About Risk Stratification Assessing risk becomes more important as prevalence increases Signs/symptoms represents a higherlevel concern for decision making than RFs Low-risk (ACSM) isolated HTN
24 More About Risk Stratification More about HTN Aggravated by exercise Commonly clustered with other risk factors: obesity, DM, CAD, HLP Low-risk (ACSM) isolated HTN < 160/100 mmhg = Moderate I Ex testing not necessary Physician clearance advisable
25 More About Risk Stratification More about HTN Low-risk (ACSM) isolated HTN < 160/100 mmhg = Intense I Ex testing necessary Document hemodynamic response Physician clearance advisable Stage II HTN (documented)>160/100 mmhg Phys clearance & test
26 More About Risk Stratification Individuals stratified to need medical clearance: Benefit from further assessment Benefit from professionally-guided exercise programs
27 Risk Stratification (cont.) Figure 2-3
28 Table 2-1 (p23) & Figure 2.3 (p24) after risk factors & Figure 2.4 (p32) Table 2-1 & Figure 2.3 great for a quiz Funny: need for testing could be looked at as Can I test him/her? Interpreted by qualified professionals Results documented
29 Exercise Testing and Testing Supervision Recommendations Based Upon Risk Category Figure 2-4
30 Atherosclerotic Cardiovascular Disease Risk Factors (cont.) The table of risk factors contains clinically relevant established CVD risk factor criteria that should be considered collectively when making decisions about: the level of medical clearance, the need for exercise testing prior to initiating participation, and the level of supervision for both exercise testing and exercise program participation.
31 Exercise Testing and Participation Recommendations Based Upon Risk Category Once the risk category has been established for an individual as low, medium, or high, appropriate recommendations may be made regarding: the necessity for medical examination and clearance before initiating a physical activity/exercise program or substantially changing the FITT framework of an existing physical activity/exercise program,
32 Exercise Testing and Participation Recommendations Based Upon Risk Category (cont.) the necessity for an exercise test before initiating a physical activity/exercise program or substantially changing the FITT framework of an existing activity program, and the necessity for physician supervision when participating in a maximal or submaximal exercise test.
33
34 Exercise Testing: Risk & Supervision Risk of CV events increases with I In all situations where testing is performed: BLS all staff, ACLS at least some staff Whenever possible test should be performed by ACSM certified staff because: These credentials document the KSAs directly related to exercise testing
35 Box 2-2 AHA Risk Stratification Criteria: Class A: Know it, live it, love it A-1 Children, adolescents, Men <45, Women <55 years old No S/S of heart disease No presence of heart disease No major RFs for CVDs A-2 Men >45, Women >55 years old No S/S of heart disease No presence of heart disease <2 major RFs for CVDs
36 Box 2-2 AHA Risk Stratification Criteria: Class A: Know it, live it, love it A-3 Men >45, Women >55 years old No S/S of heart disease No presence of heart disease >2 major RFs for CVDs No restrictions other than basic guidelines ECG & BP monitoring not required No supervision necessary A-2 & A-3 should have medical clearance A-2,3 should have medically-supervised exercise test prior to an I = vigorous exercise training.
37 Box 2-2 AHA Risk Stratification Criteria: Class B: What you need to know: RHR< 100 bpm? Exercise tolerance >6 METs? Normal BP response to graded exercise? Can they monitor their own I? (RPE, Pulse, knows S/S etc.) Physician clearance as stable disease? No to above questions or Class C we don t need to know we won t be working with them
38 Blood Pressure Lab: Keep practicing See one Do one Teach one
Section 02: Health Appraisal / Risk Stratification
Section 02: Health Appraisal / Risk Stratification ACSM Guidelines: Chapter 2 Pre Participation Health Screening and Risk Stratification ACSM Manual: Chapter 2 Pre Assessment Screening HPHE 4450 Dr. Cheatham
More informationAdult Pre Participation Screening and Exercise Prescription Practicum
Adult Pre Participation Screening and Exercise Prescription Practicum Objectives of this exercise: To administer pre participation screening and risk stratification for clients To write an appropriate
More informationContra-indications, Risks, and Safety Precautions for Stress Testing. ACSM guidelines, pg 20 7 ACSM RISK FACTORS. Risk Classifications pg 27
Contra-indications, Risks, and Safety Precautions for Stress Testing Data to Support Stress Testing How safe is stress testing? Contra-indications Termination Criteria Ellstad Chapt 5 ACSM Chapts 3-6 Seattle
More informationResistance Training 101 Workshop
UBC BodyWorks Fitness Centre Clinical Prevention Services Resistance Training 101 Workshop Presented By: Christina WM Sequeira, MKIN ACSM Certified Clinical Exercise Physiologist CSEP Exercise Physiologist
More informationChapter 08. Health Screening and Risk Classification
Chapter 08 Health Screening and Risk Classification Preliminary Health Screening and Risk Classification Protocol: 1) Conduct a Preliminary Health Evaluation 2) Determine Health /Disease Risks 3) Determine
More informationResults of the physical activity assessments from Boukje Groot
Results of the physical activity assessments from Boukje Groot Student: Suzanne Doolaard Studentnumber: 130599018 Teacher: Nuno Pimenta Course: Exercise Testing and Prescription Date: 02-05-2014 Table
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationPRESENTED BY BECKY BLAAUW OCT 2011
PRESENTED BY BECKY BLAAUW OCT 2011 Introduction In 1990 top 5 causes of death and disease around the world: Lower Respiratory Tract Infections Diarrhea Conditions arising during pregnancy Major Depression
More informationSue Scherer, PT, PhD 1
Echocardiography Is my Patient at Risk for Heart Attack? Assessing Cardio-Vascular Risk in the Physical Therapy Setting We want healthy heart function Susan Scherer, PT, PhD Associate Professor Regis University
More informationCardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
More informationStandards of Medical Care in Diabetes 2016
Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationSES-2350: EXERCISE FOR SPECIAL POPULATIONS
SES-2350: Exercise for Special Populations 1 SES-2350: EXERCISE FOR SPECIAL POPULATIONS Cuyahoga Community College Viewing:SES-2350 : Exercise for Special Populations Board of Trustees: 2017-03-30 Academic
More informationJoslin Diabetes Center Primary Care Congress for Cardiometabolic Health 2013 The Metabolic Syndrome: Is It a Valid Concept?
The Metabolic Syndrome: A Defeated Emperor What were (are) the problems? Well 1. There was no agreed upon pathogenic reason to identify people with the metabolic syndrome 2. It was a relatively poor way
More information4. American College of Sports Medicine, American Heart Association. Exercise and acute cardiovascular events: placing the risks into perspective.
4. American College of Sports Medicine, American Heart Association. Exercise and acute cardiovascular events: placing the risks into perspective. Med Sci Sports Exerc. 2007;39(5):886 97. Prevention of
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationHypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic
Hypertension in 2015: SPRINT-ing ahead of JNC-8 MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Conflits of interest? None Disclaimer The opinions contained herein are not to be considered
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationADULT PRE-EXERCISE SCREENING TOOL
ADULT PRE-EXERCISE SCREENING TOOL This screening tool does not provide advice on a particular matter, nor does it substitute for advice from an appropriately qualified medical professional. warranty of
More informationGENERAL SAFETY INDUCTION INFORMATION SCHOOL OF HEALTH SCIENCES EXERCISE SCIENCE LABORATORIES (G127/C003/EXERCISE CLINIC)
GENERAL SAFETY INDUCTION INFORMATION SCHOOL OF HEALTH SCIENCES EXERCISE SCIENCE LABORATORIES (G127/C003/EXERCISE CLINIC) IMPORTANT Please note that before participating in a practical class you must complete
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationEXERCISE PRESCRIPTION FOR OBESE PATIENT
EXERCISE PRESCRIPTION FOR OBESE PATIENT ASSOC. PROF. DR. MOHD NAHAR AZMI MOHAMED HEAD, SPORTS MEDICINE DEPARTMENT SENIOR MEDICAL LECTURER / CONSULTANT SPORTS PHYSICIAN UNIVERSITI MALAYA MEDICAL CENTER
More information2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE
2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE Massimo F Piepoli, MD, PhD, FESC, Piacenza, Italy on behalf of the 6 th Joint Task Force 2 3 Guidelines still based upon the principles of
More informationExercise prescription in primary care setting
Exercise prescription in primary care setting Mohamad Shariff A Hamid MBBS (Adelaide), MMed Sports Med (UM), PhD (UM) Sports Medicine Unit University of Malaya Summary Introduction Screening Goal setting
More informationPrescription Fitness. Robert M. Pepper, DO, FAAFP. ACOFP 55th Annual Convention & Scientific Seminars
Prescription Fitness Robert M. Pepper, DO, FAAFP 8 ACOFP 55th Annual Convention & Scientific Seminars RX: FITNESS Robert M Pepper, DO, FAAFP Assistant Dean for Predoctoral Clinical Education West Virginia
More informationCase Study: Chris Arden. Peripheral Arterial Disease
Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she
More informationEgyptian Hypertension Guidelines
Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationChapter 5: Health Screening. ACE Personal Trainer Manual Third Edition
Chapter 5: Health Screening ACE Personal Trainer Manual Third Edition Introduction The American College of Sports Medicine (ACSM) has defined what is considered moderate and vigorous exercise: Moderate
More informationPREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN
1980 to 2000: Death rate fell from: 542.9 to 266.8 per 100K men 263.3 to 134.4 per 100K women 341,745 fewer deaths from CHD in 2000 Ford ES, NEJM, 2007 47% from CHD treatments, 44% from risk factor modification
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More information7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)
University Pharmacy 5254 Anthony Wayne Drive Detroit, MI 48202 (313) 831-2008 Be able to identify the signs of a heart attack or stoke Identify what puts you at a higher risk for cardiovascular disease,
More informationBlood Pressure Measurement (children> 3 yrs)
Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationOptimizing Postpartum Maternal Health to Prevent Chronic Diseases
Optimizing Postpartum Maternal Health to Prevent Chronic Diseases Amy Loden, MD, FACP, NCMP Disclosures Research: None Financial: none applicable to this presentation PRIUM QEssentials Market Research
More informationASSeSSing the risk of fatal cardiovascular disease
ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril
More informationSection 03: Pre Exercise Evaluations and Risk Factor Assessment
Section 03: Pre Exercise Evaluations and Risk Factor Assessment ACSM Guidelines: Chapter 3 Pre Exercise Evaluations ACSM Manual: Chapter 3 Risk Factor Assessments HPHE 4450 Dr. Cheatham Purpose The extent
More informationPatient is healthy with no chronic disease or significant risk factors [16%].
AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II
More informationAdult Diabetes Clinician Guide NOVEMBER 2017
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Diabetes Clinician Guide Introduction NOVEMBER 2017 This evidence-based guideline summary is based on the 2017 KP National Diabetes Guideline.
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationADULT PRE-EXERCISE SCREENING TOOL
ADULT PRE-EXERCISE SCREENING TOOL This screening tool does not provide advice on a particular matter, nor does it substitute for advice from an appropriately qualified medical professional- warranty of
More informationYuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China
What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4
More informationDisclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?
Disclosures JUPITER: The final frontier in statin utilization or an idea from outer space? Kathy E. Komperda, PharmD, BCPS Midwestern University Chicago College of Pharmacy kkompe@midwestern.edu 4/25/09
More informationChoosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018
Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018 Choosing the Appropriate Stress Test: Does it Really Matter? Brett C. Stoll, MD, FACC February 24, 2018 Conflicts of Interest
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationPrevention of MACROvascular Complications of Diabetes
Prevention of MACROvascular Complications of Diabetes Matt Bouchonville, MD, CDE Endocrinology Division University of New Mexico School of Medicine July 12, 2018 Conflicts of Interest None Objectives 1.
More informationWomen and Coronary Artery Disease. Aren t Women Just Like Men?
Women and Coronary Artery Disease Aren t Women Just Like Men? Anita Wokhlu, MD Assistant Professor of Medicine UF Shands Gainesville, FL Wed Feb 1, 2017 CP1310268-1 Disclosure Of Relationships Anita Wokhlu,
More informationWomen and Vascular Disease
Women and Vascular Disease KEVIN F. REBECK PA-C VASCULAR TRANSPLANT SURGERY 1 The Scope of the Problem One woman dies every minute from cardiovascular disease in the U.S.! The Scope of the Problem CVD
More informationHypertension Guidelines 2017
Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,
More informationMetabolic Syndrome: A Preventable & Treatable Cluster of Conditions
Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions April D. McNeill MD Candidate 2016, Southern Illinois University, School of Medicine GE-NMF Primary Care Leadership Program, July 2013
More informationClinical Considerations of High Intensity Interval Training (HIIT)
Clinical Considerations of High Intensity Interval Training (HIIT) Jenna Taylor Exercise Physiologist & Dietitian The Wesley Hospital PhD Candidate The University of Queensland What is High Intensity Interval
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationsurtout qui n est PAS à risque?
3*25 min et surtout qui n est PAS à risque? 2018 ESC/ESH Hypertension Guidelines 2018 ESC-ESH Guidelines for the Management of Arterial Hypertension 28 th ESH Meeting on Hypertension and Cardiovascular
More informationDisclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2014 AAHP Fall Seminar Sherry Myatt, PharmD, BCPS Assistant Director of Pharmacy for
More informationJanice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES
Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationDiabetes and the Heart
Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More information2017 Employee Wellness Health Assessment Report
Employee Wellness National Consortium for Building Healthy Academic Communities (BHAC) Healthier Tennessee Workplace 2017 Employee Wellness Health Assessment Report Blood Pressure 2017 (387 total) (National
More informationFAQ Update to ACSM s Recommendations for Exercise Preparticipation Health Screening
FAQ Update to ACSM s Recommendations for Exercise Preparticipation Health Screening General Questions Q: What changed in the recommendations for exercise preparticipation health screening? A: An expert
More informationWhat is hypertension?
HYPERTENSION What is hypertension? Abnormally elevated arterial blood pressure that is usually indicated by an adult systolic blood pressure of 140 mm Hg or greater or a diastolic blood pressure of 90
More informationAerobic Exercise Screening Stratification Tool
Aerobic Screening Stratification Tool Disclaimer: The Aerobics Screening Stratification Tool is a working document currently used within the Stroke Rehabilitation Service of Toronto Rehabilitation Institute
More informationPhilippine Practice Guidelines for the Diagnosis & Management of Type 2 Diabetes Mellitus
Philippine Practice Guidelines for the Diagnosis & Management of Type 2 Diabetes Mellitus Iris Thiele Isip Tan MD, MSc, FPCP, FPSEM Chief, Medical Informatics Unit Associate Professor IV, UP College of
More informationIdentification of subjects at high risk for cardiovascular disease
Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet
More informationDiscussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting
Session #5 Cardiometabolic Risk Management in the Primary Care Setting Sonja Reichert, MD MSc FCFP FACPM Betty Harvey, RNEC BScN MScN Amanda Mikalachki, RN BScN CDE S Discussion points Whom should we be
More informationThe Latest Generation of Clinical
The Latest Generation of Clinical Guidelines: HTN and HLD Dave Brackett Clinical Guideline Purpose Uniform approach Awareness of key details Diagnosis Treatment Monitoring Evidence based approach Inform
More informationCARDIOVASCULAR FITNESS CENTER COMMUNITY PROGRAM
CARDIOVASCULAR FITNESS CENTER COMMUNITY PROGRAM The Community Exercise Program (located on the 1st floor of Mountainside Medical Center) is a medically supervised program for individuals who wish to learn
More informationPresenter Disclosure Information
Prediabetes & Type 2 Diabetes Prevention Cari Ritter, PA-C Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationHEALTH/MEDICAL QUESTIONNAIRE PHYSICAL ACTIVITY READINESS QUESTIONNAIRE (PAR-Q)
WRC Staff Use Only WRC Staff Initials Physician s Clearance received? Yes No N/A Orientation complete? Yes No Health/Medical History form signed? Yes No Assumption of Risk form signed? Yes No PAR-Q signed?
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationNorthwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?
Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA Senior Associate Dean Chair, Department of Preventive
More informationTo reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.
E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs
More informationAndrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University
CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients
More informationCPT Tyler J. Raymond D.O., M.P.H. NCS ACOFP Annual Meeting Friday, August 16, 2013
CPT Tyler J. Raymond D.O., M.P.H. NCS ACOFP Annual Meeting Friday, August 16, 2013 Discuss the current obesity epidemic Effects of exercise on morbidity and mortality Review physical activity recommendations
More informationDiabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018
Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Points to Ponder ASCVD is the leading cause of morbidity
More informationAdolescent Hypertension Roles of obesity and hyperuricemia. Daniel Landau, MD Pediatrics, Soroka University Medical Center
Adolescent Hypertension Roles of obesity and hyperuricemia Daniel Landau, MD Pediatrics, Soroka University Medical Center Blood Pressure Tables BP standards based on sex, age, and height provide a precise
More informationBlood Pressure LIMBO How Low To Go?
Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationDiagnosis and Management of Type 2 Diabetes Mellitus in Adults
Quality Improvement Support: Diagnosis and Management of Type 2 Diabetes Mellitus in Adults The Aims and Measures section is intended to provide guideline users with a menu of measures for multiple purposes,
More informationSummary of 2012/13 QOF Changes
Summary of QOF Changes Retirements 2011/12 CHD13 AF4 QP1 QP2 QP3 QP4 QP5 2011/12 Indicator Wording Threshold For patients with newly diagnosed angina (diagnosed after 1 April 2011), the percentage who
More informationUniversity of Toronto Rotation Specific Objectives. cardiac rehabilitation
University of Toronto Rotation Specific Objectives Cardiac Rehabilitation For this rotation, please FOCUS the evaluation on the following CanMEDs roles: 1) Medical Expert; 2) Collaborator; 3) Health Advocate
More information4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for
+ Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics
More informationDiabetes and Hypertension
Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for
More informationPOTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK
POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK Author: CHARLOTTE SIMPSON, SPECIALTY REGISTAR PUBLIC HEALTH (ST3), CHESHIRE EAST COUNCIL/MERSEY DEANERY SUMMARY
More informationCHEST PAIN CDU INCLUSION CRITERIA
CHEST PAIN CDU INCLUSION CRITERIA No clinical criteria for ACS Stable vital signs Initial ECG and cardiac biomarkers not consistent with ACS Low to intermediate ACS risk (HEART score 0-6) [Ref 1, 2] Plan
More informationPIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia
PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,
More informationImpact of Exercise on Patients with Diabetes Mellitus. Learning Objectives. Definitions Physical Activity and Health
Impact of Exercise on Patients with Diabetes Mellitus Bret Goodpaster, Ph.D. Exercise Physiologist Assistant Professor of Medicine University of Pittsburgh Division of Endocrinology and Metabolism Learning
More informationCase Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic
Case Discussions: Treatment Strategies for High Risk Populations Peter H. Jones MD, FNLA Associate Professor Methodist DeBakey Heart and Vascular Center Baylor College of Medicine Most Common Reasons for
More informationStandards of Medical Care In Diabetes
Standards of Medical Care In Diabetes - 2017 Robert E. Ratner, MD, FACP, FACE Professor of Medicine Georgetown University School of Medicine Disclosed no conflict of interest Standards of Care Professional.diabetes.org/SOC
More information2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary
2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationQ&A. DEMO Version
ACSM Exercise Specialist Exam Q&A DEMO Version Copyright (c) 2010 Chinatag LLC. All rights reserved. Important Note Please Read Carefully For demonstration purpose only, this free version Chinatag study
More informationMetabolic Syndrome and Chronic Kidney Disease
Metabolic Syndrome and Chronic Kidney Disease Definition of Metabolic Syndrome National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Abdominal obesity, defined as a waist circumference
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More information